Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters.

Frequent treatment of the growth-restricted (IUGR) ovine fetus with intra-amniotic IGF-1 increases fetal growth. We aimed to determine whether increased growth was maintained with an extended dosing interval and to examine possible mechanisms. Pregnant ewes were allocated to three groups: Control, a...

Full description

Bibliographic Details
Main Authors: Jibran A Wali, Hendrina A de Boo, José G B Derraik, Hui Hui Phua, Mark H Oliver, Frank H Bloomfield, Jane E Harding
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22629469/?tool=EBI
_version_ 1818401745897783296
author Jibran A Wali
Hendrina A de Boo
José G B Derraik
Hui Hui Phua
Mark H Oliver
Frank H Bloomfield
Jane E Harding
author_facet Jibran A Wali
Hendrina A de Boo
José G B Derraik
Hui Hui Phua
Mark H Oliver
Frank H Bloomfield
Jane E Harding
author_sort Jibran A Wali
collection DOAJ
description Frequent treatment of the growth-restricted (IUGR) ovine fetus with intra-amniotic IGF-1 increases fetal growth. We aimed to determine whether increased growth was maintained with an extended dosing interval and to examine possible mechanisms. Pregnant ewes were allocated to three groups: Control, and two IUGR groups (induced by placental embolization) treated with weekly intra-amniotic injections of either saline (IUGR) or 360 µg IGF-1 (IGF1). IUGR fetuses were hypoxic, hyperuremic, hypoglycemic, and grew more slowly than controls. Placental glucose uptake and SLC2A1 (GLUT2) mRNA levels decreased in IUGR fetuses, but SLC2A3 (GLUT3) and SLC2A4 (GLUT4) levels were unaffected. IGF-1 treatment increased fetal growth rate, did not alter uterine blood flow or placental glucose uptake, and increased placental SLC2A1 and SLC2A4 (but not SLC2A3) mRNA levels compared with saline-treated IUGR animals. Following IGF-1 treatment, placental mRNA levels of isoforms of the system A, y(+), and L amino acid transporters increased 1.3 to 5.0 fold, while the ratio of phosphorylated-mTOR to total mTOR also tended to increase. Weekly intra-amniotic IGF-1 treatment provides a promising avenue for intra-uterine treatment of IUGR babies, and may act via increased fetal substrate supply, up-regulating placental transporters for neutral, cationic, and branched-chain amino acids, possibly via increased activation of the mTOR pathway.
first_indexed 2024-12-14T07:57:21Z
format Article
id doaj.art-4d83986a43544c68860ddb6cf9b67d2d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T07:57:21Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4d83986a43544c68860ddb6cf9b67d2d2022-12-21T23:10:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3789910.1371/journal.pone.0037899Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters.Jibran A WaliHendrina A de BooJosé G B DerraikHui Hui PhuaMark H OliverFrank H BloomfieldJane E HardingFrequent treatment of the growth-restricted (IUGR) ovine fetus with intra-amniotic IGF-1 increases fetal growth. We aimed to determine whether increased growth was maintained with an extended dosing interval and to examine possible mechanisms. Pregnant ewes were allocated to three groups: Control, and two IUGR groups (induced by placental embolization) treated with weekly intra-amniotic injections of either saline (IUGR) or 360 µg IGF-1 (IGF1). IUGR fetuses were hypoxic, hyperuremic, hypoglycemic, and grew more slowly than controls. Placental glucose uptake and SLC2A1 (GLUT2) mRNA levels decreased in IUGR fetuses, but SLC2A3 (GLUT3) and SLC2A4 (GLUT4) levels were unaffected. IGF-1 treatment increased fetal growth rate, did not alter uterine blood flow or placental glucose uptake, and increased placental SLC2A1 and SLC2A4 (but not SLC2A3) mRNA levels compared with saline-treated IUGR animals. Following IGF-1 treatment, placental mRNA levels of isoforms of the system A, y(+), and L amino acid transporters increased 1.3 to 5.0 fold, while the ratio of phosphorylated-mTOR to total mTOR also tended to increase. Weekly intra-amniotic IGF-1 treatment provides a promising avenue for intra-uterine treatment of IUGR babies, and may act via increased fetal substrate supply, up-regulating placental transporters for neutral, cationic, and branched-chain amino acids, possibly via increased activation of the mTOR pathway.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22629469/?tool=EBI
spellingShingle Jibran A Wali
Hendrina A de Boo
José G B Derraik
Hui Hui Phua
Mark H Oliver
Frank H Bloomfield
Jane E Harding
Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters.
PLoS ONE
title Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters.
title_full Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters.
title_fullStr Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters.
title_full_unstemmed Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters.
title_short Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters.
title_sort weekly intra amniotic igf 1 treatment increases growth of growth restricted ovine fetuses and up regulates placental amino acid transporters
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22629469/?tool=EBI
work_keys_str_mv AT jibranawali weeklyintraamnioticigf1treatmentincreasesgrowthofgrowthrestrictedovinefetusesandupregulatesplacentalaminoacidtransporters
AT hendrinaadeboo weeklyintraamnioticigf1treatmentincreasesgrowthofgrowthrestrictedovinefetusesandupregulatesplacentalaminoacidtransporters
AT josegbderraik weeklyintraamnioticigf1treatmentincreasesgrowthofgrowthrestrictedovinefetusesandupregulatesplacentalaminoacidtransporters
AT huihuiphua weeklyintraamnioticigf1treatmentincreasesgrowthofgrowthrestrictedovinefetusesandupregulatesplacentalaminoacidtransporters
AT markholiver weeklyintraamnioticigf1treatmentincreasesgrowthofgrowthrestrictedovinefetusesandupregulatesplacentalaminoacidtransporters
AT frankhbloomfield weeklyintraamnioticigf1treatmentincreasesgrowthofgrowthrestrictedovinefetusesandupregulatesplacentalaminoacidtransporters
AT janeeharding weeklyintraamnioticigf1treatmentincreasesgrowthofgrowthrestrictedovinefetusesandupregulatesplacentalaminoacidtransporters